Alzheimer's disease (AD) is the most common cause of dementia worldwide, and its
prevalence is rapidly increasing due to extended lifespans. Among the increasing number of …

Alzheimer disease (AD) is a significant cause of morbidity and mortality worldwide, with
limited treatment options and considerable diagnostic challenges. Identification and …

Aims We mainly evaluate retinal alterations in Alzheimer's disease (AD) patients, investigate
the associations between retinal changes with AD biomarkers, and explore an optimal …

The pathognomonic hallmark of Parkinson's disease (PD), α-synuclein, has been observed
in the retina of PD patients. We investigated whether biomarkers in the tears and retinal …

We aimed to evaluate the diagnostic role of Alzheimer's disease (AD) biomarkers in tears as
well as their association with retinal and choroidal microstructures. In a cross-sectional …

Purpose To assess the baseline differences and longitudinal rate of change in retinal and
choroidal imaging parameters between apolipoprotein ε4 (APOE ε4) carriers and …

Many human neural or neurodegenerative diseases strongly affect the ocular and retinal
environment showing peculiar alterations which can be employed as specific disease …

INTRODUCTION We investigated whether retinal capillary perfusion is a biomarker of
cerebral small vessel disease and impaired cognition among Black Americans, an …

Alzheimer's Disease (AD) is a complex neurodegenerative disease resulting in progressive
loss of memory, language and motor abilities caused by cortical and hippocampal …

While Alzheimer's disease and other neurodegenerative diseases have traditionally been
viewed as brain disorders, there is growing evidence indicating their manifestation in the …